---
title: "ROYSTON AARON — Ownership Dossier"
canonical: https://whiteintel.dev/entity/08341ffa-b6ad-5e83-b532-11bcad7b92d7
json: https://whiteintel.dev/api/public/dossier/08341ffa-b6ad-5e83-b532-11bcad7b92d7
identifier: sec:0001727703
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ROYSTON AARON

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001727703`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/08341ffa-b6ad-5e83-b532-11bcad7b92d7  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/08341ffa-b6ad-5e83-b532-11bcad7b92d7  

## Ownership & control

### Holdings / subsidiaries

- **ACHIEVE LIFE SCIENCES, INC.** (director) — https://whiteintel.dev/entity/0c7f18fd-ef3a-5985-948c-67e64ddc5e27
- **RAYZEBIO, INC.** (director) — https://whiteintel.dev/entity/84c3a732-6df0-59c0-9df6-adef1b5b6dcf
- **Ventyx Biosciences, Inc.** (director) — https://whiteintel.dev/entity/69630e64-d971-5e42-ac6c-b3a12fb5158f
- **Elevation Oncology, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/0eca026b-64aa-5f4b-94a6-10398e8f2f6e
- **Ventyx Biosciences, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/69630e64-d971-5e42-ac6c-b3a12fb5158f
- **VYNE Therapeutics Inc.** (director) — https://whiteintel.dev/entity/d382a860-279d-5548-a93d-0f56d28acd45
- **Akero Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ROYSTON AARON**. Human view: https://whiteintel.dev/entity/08341ffa-b6ad-5e83-b532-11bcad7b92d7 · Structured JSON: https://whiteintel.dev/api/public/dossier/08341ffa-b6ad-5e83-b532-11bcad7b92d7._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._